Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a **combination dietary supplement** containing standardized extracts of *ashwagandha* (Withania somnifera) and *saffron* (Crocus sativus). Ashwagandha is an adaptogen traditionally used to help the body manage stress, potentially reducing cortisol levels and promoting emotional balance, improved mood, better quality of sleep, and cognitive wellness. Saffron, rich in bioactive carotenoids, possesses antioxidant, anti-inflammatory, and mood-supporting properties, and may modulate monoaminergic neurotransmitters (such as serotonin, dopamine, and norepinephrine). Together, these ingredients are used primarily to support mental health and stress relief, with some evidence supporting improvements in mild to moderate anxiety, sleep quality, and sexual function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ashwagandha + saffron.